Primary cutaneous aspergillosis in an immunocompetent patient: successful treatment with oral voriconazole.
We report a case of primary cutaneous aspergillosis in an immunocompetent child that responded rapidly to oral voriconazole therapy. Voriconazole may be considered as a treatment option for pediatric patients with primary cutaneous aspergillosis.